Commitment GLP-1 requires ongoing treatment and lifestyle changes
Aren't affordable options critical for accessibility to effective weight management solutions
Patients should never attempt to use medication that has been frozen, as doing so may result in inadequate glycemic control, treatment failure, or unexpected adverse effects
Seven different GLP-1 receptor agonists were investigated among the trials, including semaglutide (also known as Ozempic or Wegovy), dulaglutide (Trulicity) and liraglutide (Victoza)
It is not intended for commercial sale, medical use outside research protocols, veterinary applications, or dietary supplement formulations
Placing a barrier, such as a small towel or the medication's original carton, between the ice pack and the pen prevents this risk